Get started
Author

Mona Ridderheim

Expression and prognostic significance of platelet-derived growth factor and its receptors in epithelial ovarian neoplasms.
1993 · R Henriksen, K Funa, et al. · PubMed · 220
Randomized Trial of Single Agent Paclitaxel Given Weekly Versus Every Three Weeks and with Peroral Versus Intravenous Steroid Premedication to Patients with Ovarian Cancer Previously Treated with Platinum
2002 · Per Rosenberg, Ha˚kan Andersson, et al. · Acta Oncologica · 138
PDF
The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer
2005 · Susanne Malander, Eva Rambech, et al. · Gynecologic Oncology · 126
One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations
2003 · S. Malander, M. Ridderheim, et al. · European Journal of Cancer · 92
Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: A pilot study of a new digitized scalp-cooling system used in 74 patients
2003 · Mona Ridderheim, Maria Bjurberg, et al. · Supportive Care in Cancer · 73
First-line treatment of ovarian cancer FIGO stages IIb-IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatin
2003 · G. B. Kristensen, I. Vergote, et al. · International Journal of Gynecological Cancer · 52
A Systematic Overview of Radiation Therapy Effects in Cervical Cancer (Cervix Uteri)
2003 · Nina Einhorn†, Claes Tropé, et al. · Acta Oncologica · 44
PDF
A Systematic Overview of Radiation Therapy Effects in Ovarian Cancer
2003 · Nina Einhorn†, Claes Tropé, et al. · Acta Oncologica · 38
PDF
A Single-Arm Phase II Trial of First-Line Paclitaxel in Combination with Lapatinib in HER2-Overexpressing Metastatic Breast Cancer
2010 · Agnieszka Jagiello-Gruszfeld, Sergei Tjulandin, et al. · Oncology · 37
Steroid receptors and hormones in relation to cell proliferation and apoptosis in poorly differentiated epithelial ovarian tumors
2001 · P. Lindgren, T. Backstrom, et al. · International Journal of Oncology · 34
First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)—a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTG
2012 · K. Lindemann, R.D. Christensen, et al. · Annals of Oncology · 33
PDF
A Systematic Overview of Radiation Therapy Effects in Uterine Cancer (Corpus Uteri)
2003 · Nina Einhorn†, Claes Tropé, et al. · Acta Oncologica · 24
PDF
Two BRCA1-Positive Epithelial Ovarian Tumors with Metastases to the Central Nervous System: A Case Report
2001 · Anjila Koul, Niklas Loman, et al. · Gynecologic Oncology · 15
The potential of proton beam radiation therapy in prostate cancer, other urological cancers and gynaecological cancers
2005 · Bengt Johansson, Mona Ridderheim, et al. · Acta Oncologica · 13
PDF
BRCA1 and BRCA2 mutations in ovarian cancer: Covariation with specific cytogenetic features
2000 · A. Koul, S. Malander, et al. · International Journal of Gynecological Cancer · 13
Steroid production in different parts of malignant and benign ovarian tumors in vitro.
1993 · M Ridderheim, C G Mählck, et al. · PubMed · 13
Optimized sequence of drug administration and schedule leads to improved dose delivery for gemcitabine and paclitaxel in combination: a phase I trial in patients with recurrent ovarian cancer
2006 · C.J. POOLE, T. PERREN, et al. · International Journal of Gynecological Cancer · 10
EGF/TGF-alpha and progesterone in urine of ovarian cancer patients.
1995 · M Ridderheim, S Cajander, et al. · PubMed · 10
Sequential topotecan and oral etoposide in recurrent ovarian carcinoma pretreated with platinum‐taxane
2005 · Bo Gronlund, Svend A. Engelholm, et al. · Cancer · 9
TP53 protein expression analysis by luminometric immunoassay in comparison with gene mutation status and prognostic factors in early stage endometrial cancer
2002 · A. Koul, P.-O. Bendahl, et al. · International Journal of Gynecological Cancer · 7
Total prevention of taxoid-induced alopecia by a new model of cold cap (dignitana)
1999 · L. Lundgren-Eriksson, G. Edbom, et al. · European Journal of Cancer · 7
Updated efficacy and safety assessment of first-line therapy with lapatinib, trastuzumab, and paclitaxel in HER2+ metastatic breast cancer.
2010 · F. J. Esteva, S. Franco, et al. · Journal of Clinical Oncology · 6
Phase 1 study to investigate alternate sequencing of the combination of gemcitablne and paclitaxel in ovarian carcinoma
1997 · C.J. Poole, T. Perren, et al. · European Journal of Cancer · 6
Progesterone and estradiol stimulate release of epidermal growth factor/transforming growth factor alpha by ovarian tumours in vitro.
1995 · M Ridderheim, U Stendahl, et al. · PubMed · 6
Steroid-hormone Production and Receptors in Relation to Ki-67, P53, S-phase Fraction and Ploidy in Epithelial Ovarian-tumors
1995 · M RIDDERHEIM, B TRIBUKAIT, et al. · International Journal of Oncology · 3
Works count: 33
Citation count: 1,036
H-index: 13
I10-index: 18
Year
Topic
Type